@article{Brown2017,
  doi = {10.18553/jmcp.2017.23.9.958},
  url = {https://doi.org/10.18553/jmcp.2017.23.9.958},
  year = {2017},
  month = sep,
  publisher = {Academy of Managed Care Pharmacy},
  volume = {23},
  number = {9},
  pages = {958--967},
  author = {Joshua D. Brown and Anand R. Shewale and Jeffery C. Talbert},
  title = {Adherence to Rivaroxaban,  Dabigatran,  and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data},
  journal = {Journal of Managed Care {\&} Specialty Pharmacy}
}

{"_id":"MYHWG9iyQD9p7wPTY","bibbaseid":"brown-shewale-talbert-adherencetorivaroxabandabigatranandapixabanforstrokepreventionfornewlydiagnosedandtreatmentnaiveatrialfibrillationpatientsanupdateusing20132014data-2017","author_short":["Brown, J. D.","Shewale, A. R.","Talbert, J. C."],"bibdata":{"bibtype":"article","type":"article","doi":"10.18553/jmcp.2017.23.9.958","url":"https://doi.org/10.18553/jmcp.2017.23.9.958","year":"2017","month":"September","publisher":"Academy of Managed Care Pharmacy","volume":"23","number":"9","pages":"958–967","author":[{"firstnames":["Joshua","D."],"propositions":[],"lastnames":["Brown"],"suffixes":[]},{"firstnames":["Anand","R."],"propositions":[],"lastnames":["Shewale"],"suffixes":[]},{"firstnames":["Jeffery","C."],"propositions":[],"lastnames":["Talbert"],"suffixes":[]}],"title":"Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data","journal":"Journal of Managed Care & Specialty Pharmacy","bibtex":"@article{Brown2017,\n doi = {10.18553/jmcp.2017.23.9.958},\n url = {https://doi.org/10.18553/jmcp.2017.23.9.958},\n year = {2017},\n month = sep,\n publisher = {Academy of Managed Care Pharmacy},\n volume = {23},\n number = {9},\n pages = {958--967},\n author = {Joshua D. Brown and Anand R. Shewale and Jeffery C. Talbert},\n title = {Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data},\n journal = {Journal of Managed Care {\\&} Specialty Pharmacy}\n}\n\n","author_short":["Brown, J. D.","Shewale, A. R.","Talbert, J. C."],"key":"Brown2017-1","id":"Brown2017-1","bibbaseid":"brown-shewale-talbert-adherencetorivaroxabandabigatranandapixabanforstrokepreventionfornewlydiagnosedandtreatmentnaiveatrialfibrillationpatientsanupdateusing20132014data-2017","role":"author","urls":{"Paper":"https://doi.org/10.18553/jmcp.2017.23.9.958"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://raw.githubusercontent.com/rockey63/rockey63/master/student_bibbase","dataSources":["5GTJhiHssnvqFvaWq"],"keywords":[],"search_terms":["adherence","rivaroxaban","dabigatran","apixaban","stroke","prevention","newly","diagnosed","treatment","naive","atrial","fibrillation","patients","update","using","2013","2014","data","brown","shewale","talbert"],"title":"Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data","year":2017}